ts-134
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 21, 2015 (NCT03746067)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ts-134
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05401227 | Phase 1 | Dec 15, 2022 | Columbia University, National Institute of Mental Health (NIMH) |
| NCT03141658 | Phase 1 | Jun 1, 2017 | Columbia University, Taisho Pharmaceutical |
| NCT03742791 | Phase 1 | Jun 28, 2016 | Taisho Pharmaceutical |
| NCT03746067 | Phase 1 | Aug 21, 2015 | Taisho Pharmaceutical |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Taisho Pharmaceutical | For profit | 3 | 3 | 1 | 2015 |
| Columbia University | Academic/Hospital | 2 | 1 | 1 | 2017 |
| National Institute of Mental Health (NIMH) | Government | 1 | 0 | 1 | 2022 |
3 organizations
Page 1 / 1